Kura Oncology, Inc.KURANASDAQ
Loading
Year-over-year free cash flow growth rate
Latest
238.17%
↑ 2271% vs avg
Percentile
P97
Near historical high
Streak
1 qtr
Consecutive growthAccelerating
Average
10.04%
Historical baseline
| Period | Value |
|---|---|
| Q4 2025 | 238.17% |
| Q3 2025 | -175.16% |
| Q2 2025 | 58.13% |
| Q1 2025 | -126.87% |
| Q4 2024 | 718.69% |
| Q3 2024 | -2.10% |
| Q2 2024 | 13.04% |
| Q1 2024 | -42.55% |
| Q4 2023 | -18.17% |
| Q3 2023 | -12.97% |
| Q2 2023 | 28.39% |
| Q1 2023 | -35.29% |
| Q4 2022 | -24.08% |
| Q3 2022 | 29.92% |
| Q2 2022 | 5.29% |
| Q1 2022 | -37.34% |
| Q4 2021 | 7.30% |
| Q3 2021 | 10.75% |
| Q2 2021 | 0.64% |
| Q1 2021 | -53.62% |
| Q4 2020 | -5.40% |
| Q3 2020 | -14.09% |
| Q2 2020 | 24.00% |
| Q1 2020 | -45.93% |
| Q4 2019 | -14.72% |
| Q3 2019 | 15.84% |
| Q2 2019 | -1.26% |
| Q1 2019 | -39.57% |
| Q4 2018 | 21.46% |
| Q3 2018 | -3.25% |
| Q2 2018 | 2.02% |
| Q1 2018 | -71.94% |
| Q4 2017 | -19.87% |
| Q3 2017 | -2.05% |
| Q2 2017 | 29.13% |
| Q1 2017 | -27.96% |
| Q4 2016 | -23.14% |
| Q3 2016 | 6.06% |
| Q2 2016 | 20.36% |
| Q1 2016 | -30.14% |